BioSpace News Archive

The Epilepsy Foundation today announced it has awarded New Therapy Commercialization Grants totaling $300,000 to leading scientists with the goal of accelerating the development of therapies for those living with poorly controlled seizures.

Today, Southworth Associates International announced that the well-known international behavioral health services firm has been acquired by interventionist/executive Benjamin Seymour.

Berkeley Lights Further Extends into Asian Market

Lemborexant taken at bedtime had no significant effect on automobile driving performance the next morning in healthy adult and elderly volunteers

NationsHearing, LLC., a leader in the hearing healthcare industry, today announced their customer relationship management (CRM) application and the underlying supporting infrastructure has earned Certified status for information security by HITRUST.

Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a research and development-focused biotechnology company dedicated to creating small molecule drugs for viral infections and liver diseases, today announced that it plans to report its financial results for its fiscal first quarter ended December 31, 2018 after the U.S. markets close on February 6, 2019.

Seattle Genetics, Inc. (Nasdaq: SGEN) announced today that it will report its fourth quarter and full year 2018 financial results on Thursday, February 7, 2019 after the close of financial markets.

OptraSCAN®, the leading On-Demand Digital Pathology solution provider, today announced the expansion of their Medical Advisory Board with two key appointments, namely, Dr. Thomas J. Montine, MD, PhD, Chairman, Department of Pathology at Stanford University School of Medicine; and Dr. Jon S. Morrow, M.D., Ph.D., Chairman, Department of Pathology at Yale School of Medicine.

Biotech Showcase™, one of the most influential international biotechnology investor conferences in the world, concluded in San Francisco the second week of January and brought together more than 3,600 decision makers and biotech investors shaping the biopharmaceutical industry.

Masimo (NASDAQ: MASI) announced today the U.S. launch of Iris® Device Management System (Iris DMS), an automation and connectivity solution designed to streamline management of Masimo devices used throughout a hospital system.